test

Pilot Study of Sorafenib and Bi-weekly Capecitabine in Patients with Advanced Breast and Gastrointestinal Tumors

Conditions

Breast - Female | Colon | Esophagus | Rectum | Stomach

Trial Phase

Phase I

Trial Purpose and Description

Trial Purpose

Dose finding, toxicity assessment


Participation Guidelines

Age:
Gender:

Eligibility Criteria

Sponsor:
Yale Cancer Center
Dates:
08/12/2012
Last Updated:
Study HIC#:
1112009424